Qritive at the Digital Pathology Malaysia 2023
The Qritive team had a great time attending the Digital Pathology Malaysia event at Kuala Lampur alongside our esteemed partner, Motic!
The Qritive team had a great time attending the Digital Pathology Malaysia event at Kuala Lampur alongside our esteemed partner, Motic!
Qritive, a leading provider of digital pathology solutions, announced the launch of a new AI (Artificial Intelligence) module, QAi Prostate, for prostate cancer diagnosis. Using advanced machine learn
Corista, a leading provider of clinical, research and educational digital pathology image management solutions, and Qritive, a leading developer of artificial intelligence (AI)-powered cancer diagnost
Colorectal cancer is one of the most common cancers worldwide, accounting for an annual estimated 1.8 million incident cases. With the increasing number of colonoscopies being perf
Dr Lau Hiu Yeung (Resident, Singhealth Pathology Residency Programme) giving his presentation “AI for Prostate Histopathology: A Pilot Study”, a collaboration with Qritive.
Quantitative immunohistochemistry (IHC) is an integral part of histopathology reporting, providing vital information such as tumour characterisation and prognosis. Ki-67 proliferat
Colorectal cancer is one of the most common cancers worldwide, accounting for an annual estimated 1.8 million incident cases. With the increasing number of colonoscopies being perf
Morphologic rare cell detection is a laborious, operator-dependent process which has the potential to be improved by the use of image analysis using artificial intelligence. Detect
Colorectal cancer is one of the top three cancers afflicting men and women worldwide, with an estimated 1.8 million people diagnosed in 2018. As colonoscopies become more accessibl
No posts were found for provided query parameters.
Qritive, a leading provider of digital pathology solutions, announced the launch of a new AI (Artificial Intelligence) module, QAi Prostate, for prostate cancer diagnosis. Using advanced machine learn
Corista, a leading provider of clinical, research and educational digital pathology image management solutions, and Qritive, a leading developer of artificial intelligence (AI)-powered cancer diagnost
We’re excited to announce that Qritive will be attending the USCAP 2023 conference! The conference will take place from March 11-16, 2023, in New Orleans, Louisiana. Come visit us in booth #460.
The Magazine of the Algorithm Community with Bruno Occhipinti, Chief Commercial Office of Qritive, at MICCAI 2022.
Featured interview of Aneesh Sathe, CEO and Co-founder of Qritive, in Technode Global on ‘Qritive’s aim to improve cancer diagnosis through AI’
The synergy of human and AI-based insights in cancer pathology can open avenues for early cancer detection for better patient-specific assessment and treatment
No posts were found for provided query parameters.
No posts were found for provided query parameters.
Recent Posts
The Qritive team had a great time attending the Digital Pathology Malaysia event at Kuala Lampur alongside our esteemed partner, Motic!
Most Reads
RESOURCES